|
|
EN

  • 業務谘詢

    中國：

    Email: marketing@yakkaa.com

    業務谘詢專線：400-780-8018

    （僅限服務谘詢，其他事宜請撥打川沙總部電話）

    川沙總部電話: +86 (21) 5859-1500

    海外：

    +1(626)986-9880(U.S. - West Coast)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

在線留言×
點擊切換
News information
新聞資訊

BioTrinity 2022——共同催化生命科學行業增長！

2022-04-22
|
訪問量：

BioTrinity-2022——共同催化生命科學行業增長.jpg

BioTrinity 2022 is only a couple weeks away! Medicilon is excited to attend and exhibit at the conference. Our Vice President and Business Development team will be exhibiting at the conference. We are happy to meet you in person to discuss how our services and capabilities would support your current research needs and expedite your drug discovery and development programs. We look forward to seeing you soon and wish you safe trips!
BioTrinity 2022 集行業之聲，讓中國醫藥界感知 BioTrinity 的新訊息。hjc黄金城很高興能參加此次BioTrinity 。我們歐洲團隊將出席此次會議。我們期待與您會麵並討論hjc黄金城的強大服務能力將如何支持您的研發需求，並加快您的藥物研發！
Date: April 26-27, 2022
Location: England, United Kingdom

ABOUT BioTrinity 2022何為BioTrinity？

BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person re-engagement across the life sciences industry. The event is attended by an audience of early stage and emerging life sciences R&D Companies, investors, big pharma, and other valued partners throughout the life sciences ecosystem. The conference features a focused, relevant, and stimulating programme, led by great speakers, who bring their knowledge, expertise, and vision to the fore in exciting, high-quality sessions.
❖ 這是一次生命科學行業的麵對麵深度會談。參加此次活動的有早期和新興生命科學研發公司、投資者、大型製藥公司和整個生命科學生態係統中的其他重要合作夥伴。江山代有人才出，由眾多的優秀演講者帶來新技術的分享！
❖ 七個核心治療領域——腫瘤學、中樞神經係統、微生物組、炎症、罕見病、傳染病以及人工智能和數據。

Innovative Drug R&D Services創新藥研發服務

Medicilon is an integrated contract research organization (CRO), providing comprehensive one-step new drug R&D for pharmaceutical enterprises and scientific research institutions around the world. We provide one-stop customized R&D solutions ranging from precise drug targeting to IND filing assistance.Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D.
Innovative Drug R&D Services

❖ Antibody-Drug Conjugate(ADC) R&D project

❖ PROTAC Drug Discovery Research Platform

❖ mRNA Vaccine Bioanalysis Platform

❖ Non-clinical Research for Cellular Immunotherapies

hjc黄金城深度整合研發經驗，不斷攀登研發技術高峰，搭建新藥研發一體化創新服務平台：
❖ ADC臨床前研發項目
❖ PROTAC 藥物發現技術平台
❖ mRNA疫苗生物分析技術平台
❖ 細胞免疫治療藥物平台等
相關新聞